Brain tumor vaccine study giving hope to those with deadly glioblastoma

preview_player
Показать описание
An experimental vaccine is bringing hope to those battling fatal brain tumors.

Early results show the shot doubled survival time for people with glioblastoma, a brain cancer that is usually fatal 16 months from diagnosis.

In July 2017, 10 weeks after her wedding, Katy Sanchez of Chelsea, Michigan, received a devastating diagnosis. She had a glioblastoma brain tumor, and within days had surgery to remove as much as possible. That was followed by radiation and finally chemotherapy, all of which are standard treatment.

Her father scoured the computer looking for guidance, and found a clinical trial of a brain tumor vaccine being done at Cleveland Clinic.

"You know, using an odd turn of phrase, it was kind of a 'no brainer," Katy said of not hesitating to sign up for the trial. "In the face of only having 12 or 15 months to live, you'll pretty much do anything."

Three months after her diagnosis, Sanchez went to the Clinic to start the vaccine therapy. Every 10 weeks, she returns to continue getting the shots, even now six years later. During each of those visits, she also receives an MRI to see if her tumor has returned.

Рекомендации по теме
Комментарии
Автор

Please tell me this is true. Had surgery and radiation. Going to Dana Farber April 4th. I need hope!

ddietr